Liu Yan, Zhu Min, Geng Jing, Ban Chengjun, Zhang Shu, Chen Wenhui, Ren Yanhong, He Xuan, Chen Wang, Dai Huaping
Department of Infectious Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Department of Respiratory and Critical Care Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
Clin Respir J. 2018 Apr;12(4):1700-1705. doi: 10.1111/crj.12732. Epub 2017 Dec 18.
To investigate the incidence and risk factors of lung cancer in patients with idiopathic pulmonary fibrosis (IPF), and to learn the clinical, imaging and pathological features and of lung cancer in IPF.
The study population included consecutive 268 IPF patients. Of them, 46 patients had pathologically or cytologically proven lung cancer. The demographic, clinical, HRCT and pathological features in patients with IPF and lung cancer were analysed and compared with the patients with IPF alone.
Of 268 IPF patients, 46 patients were diagnosed as IPF with lung cancer, accounted for 17.16%. 45.65% were adenocarcinoma. Lung cancer located mostly in the peripheral area and lower lobes of lungs consistent with IPF affected area. Old age and heavy smoking were risk factors of lung cancer developing in IPF. Chest pain and haemoptysis were more frequent in IPF patients with lung cancer than without lung cancer (P = .000). Nodular or mass shadows were found only in IPF patients with lung cancer (P = .000). The levels of CEA and CA125 in IPF patients were much higher in IPF patients with lung cancer (P ≤ .001). The median survival time was 36.2 ± 22.7 months in IPF patients, longer than 6.9 ± 3.3 months in IPF patients with lung cancer (P < .001).
Lung cancer frequently develops in patients with IPF, which is mainly adenocarcinoma, located in IPF affected area. Chest pain and haemoptysis are potential indicative of lung cancer developing in patients with IPF as atypical nodes or masses located in the peripheral areas and lower lobes on chest HRCT.
探讨特发性肺纤维化(IPF)患者肺癌的发病率及危险因素,了解IPF合并肺癌的临床、影像及病理特征。
研究对象为连续纳入的268例IPF患者。其中46例经病理或细胞学证实患有肺癌。分析并比较IPF合并肺癌患者与单纯IPF患者的人口统计学、临床、高分辨率CT(HRCT)及病理特征。
268例IPF患者中,46例被诊断为IPF合并肺癌,占17.16%。45.65%为腺癌。肺癌多位于肺外周及下叶,与IPF受累区域一致。高龄和重度吸烟是IPF患者发生肺癌的危险因素。IPF合并肺癌患者胸痛和咯血的发生率高于未合并肺癌的IPF患者(P = 0.000)。仅在IPF合并肺癌患者中发现结节或肿块影(P = 0.000)。IPF合并肺癌患者的癌胚抗原(CEA)和糖类抗原125(CA125)水平明显高于单纯IPF患者(P≤0.001)。IPF患者的中位生存时间为36.2±22.7个月,长于IPF合并肺癌患者的6.9±3.3个月(P<0.001)。
IPF患者常发生肺癌,主要为腺癌,位于IPF受累区域。胸痛和咯血可能提示IPF患者发生肺癌,胸部HRCT显示外周及下叶的非典型结节或肿块。